TCT
ABMD

TIAA CREF Trust’s Abiomed Inc ABMD Stock Holding History

TIAA CREF Trust’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		$1.45M Hold
11,560
– – 0.01% 248
2016
Q4 		$1.3M Sell
11,560
-37
-0.3% -$4.29K 0.01% 247
2016
Q3 		$1.49M Buy
+11,597
New +$1.39M 0.01% 228

Other funds holding ABMD

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

TIAA CREF Trust's ABMD Position: Q1 2017 in Review

TIAA CREF Trust held its Abiomed Inc (ABMD) position steady in Q1 2017 at 11,560 shares worth $1.45M. The position accounts for 0.01% of the portfolio, ranked #248.

TIAA CREF Trust first reported a position in ABMD in Q3 2016 and has held it in 3 quarters since. The position peaked at $1.49M in Q3 2016. 287 funds tracked by Wall St. Rank hold ABMD as of Q1 2017.

  • TIAA CREF Trust held 11,560 shares of Abiomed Inc worth $1.45M as of Q1 2017.
  • TIAA CREF Trust left its Abiomed Inc share count unchanged in Q1 2017.
  • Abiomed Inc made up 0.01% of TIAA CREF Trust's portfolio in Q1 2017, its #248 holding.
  • TIAA CREF Trust first reported a position in Abiomed Inc in Q3 2016 and has held it in 3 quarters since.
  • TIAA CREF Trust's Abiomed Inc position peaked at $1.49M in Q3 2016.
  • 287 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2017.

Based on TIAA CREF Trust's 13F filing for Q1 2017, filed 3 May 2017.